Bahinting, Jessa Mae .

HRN: 17-66-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CEFUROXIME 1.5GM (VIAL)
06/20/2025
06/21/2025
IV
1.5g
Anst Ptor
Repeat Cs
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: